Navigation Links
Pregnancy hormone predicts postpartum depression
Date:2/2/2009

Irvine, Calif. Women who have higher levels of a hormone produced by the placenta midway through pregnancy appear more likely to develop postpartum depression, a study authored by a UC Irvine researcher finds.

The discovery could help identify and treat women at risk for postpartum depression long before the onset of symptoms.

Ilona Yim, psychology and social behavior assistant professor, and colleagues found that women whose levels of corticotrophin-releasing hormone started to increase more rapidly around 25 weeks of gestation had a higher incidence of postpartum depression.

Normally secreted in very small amounts by the hypothalamus, this hormone regulates the body's response to stress. During pregnancy, large amounts are produced in the placenta and are associated with delivery.

"The hormone we studied plays an important part in pregnancy and has been linked to depression," Yim said. "Many factors may cause some women's bodies to produce more of this hormone during pregnancy. Evidence suggests that stress early in pregnancy could play a role."

The researchers studied the hormone-postpartum depression link using data from a larger study funded by the National Institute of Child Health and Human Development. They took blood samples from 100 pregnant women and assessed symptoms of depression throughout pregnancy, then again nine weeks after delivery.

Of the 100 women, 16 developed postpartum depression symptoms during follow-up visits. Three-fourths of those women, the study concludes, could have been identified in mid-pregnancy based solely on hormone levels.


'/>"/>

Contact: Laura Rico
lrico@uci.edu
949-824-9055
University of California - Irvine
Source:Eurekalert

Page: 1

Related biology news :

1. Smoking during pregnancy may impair thyroid function of mom and fetus
2. Previous abortions and exercise: Do they affect pregnancy?
3. Gaining too much weight during pregnancy nearly doubles risk of having a heavy baby
4. Depression during pregnancy can double risk of preterm delivery
5. Pregnancy not turning minds to mush: Study
6. Guidelines urge physical activity during pregnancy
7. New study indicates link between weight gains during pregnancy and dieting history
8. Scientists find redesigned hammer that forged evolution of pregnancy in mammals
9. Monitoring outcomes of suicide attempts in pregnancy can better assess drug dangers
10. Stem cells may solve mystery of early pregnancy breast cancer protection
11. Gap junction protein vital to successful pregnancy, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology: